Telomere Length in Myelodysplastic Syndromes

American Journal of Hematology

Volumn 56, Issue 4, 1997, Pages 266-271

  Boultwood, J ^a   Fidler, C ^a   Kusec, R ^a   Rack, K ^a   Elliott, P J W ^a   Atoyebi, O ^a   Chapman, R ^b   Oscier, D G ^b   Wainscoat, U S ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

Author keywords

Leukemia; MDS; Telomere

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD; BONE MARROW CELL; CHEMISTRY; DNA PROBE; GENETICS; GRANULOCYTE; HUMAN; KARYOTYPING; LYMPHOCYTE; MIDDLE AGED; MYELODYSPLASTIC SYNDROME; NUCLEOTIDE REPEAT; PATHOLOGY; REFERENCE VALUE; SOUTHERN BLOTTING; TELOMERE; ULTRASTRUCTURE;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, SOUTHERN; BONE MARROW CELLS; DNA PROBES; GRANULOCYTES; HUMANS; KARYOTYPING; LYMPHOCYTES; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; REFERENCE VALUES; REPETITIVE SEQUENCES, NUCLEIC ACID; TELOMERE;

EID: 0031451827     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199712)56:4<266::AID-AJH12>3.0.CO;2-7     Document Type: Article

References (40)

1. Blackburn EH: Structure and function of telomeres. Nature 350:569-573, 1991.
2. Moyzis RK, Buckingham JM, Cram LS, Dani M, Deaven LL, Jones MD, Meyne J, Ratliff RL, Wu JR: A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 85:6622-6626, 1988.
3. Blackburn EH: Telomeres: No end in sight. Cell 77:621-623, 1994.
4. Giraldo R, Rhodes D: The yeast telomere-binding protein RAP1 binds to and promotes the formation of DNA quadruplexes in telomeric DNA. EMBO J 13:2411-2420, 1994.
5. Greider CW, Blackburn EH: Identification of a specific telomere terminal transterase activity in Tetrahymena extracts. Cell 43:405-413, 1985.
6. Greider CW, Blackburn EH: A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 337:331-337, 1989.
7. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J, Le S, West MD, Harley CB, Andrews WH, Greider CW, Villeponteau: The RNA component of human telomerase. Science 269:1236-1241, 1995.
8. Harley CB, Vaziri H, Counter CM, Allsopp RC: The telomere hypothesis of cellular aging. Exp Gerontol 27:375-382, 1992.
9. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC: Telomere reduction in human colorectal carcinoma and with ageing. Nature 346:866-868, 1990.
10. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW, Harley CB: Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 89:10114-10118, 1992.
11. Harley CB, Futcher AB, Greider CW: Telomeres shorten during age-ing of human fibroblasls. Nature 345:458-460, 1990.
12. Vaziri H, Schachter F, Uchida I, Wei L, Zhu X, Effros R, Cohen D, Harley CB: Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet 52:661-667, 1993.
13. Harley CB: Telomere loss: Mitotic clock or genetic time bomb? Mutat Res 256:271-282, 1991.
14. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM: Evidence for a mitotic clock in human hematopoietic stem cells: Loss of telomeric DNA with age. Proc Natl Acad Sci USA 91:9857-9860, 1994.
15. Greider DW, Blackburn EH: Telomeres. telomerase and cancer. Sci 274:80-85, 1996.
16. Harley CB, Villeponteau B: Telomeres and telomerase in aging and cancer. Curr Opin Genet Dev 5:249-255, 1995.
17. Hiyama E, Hiyama K, Yokoyama T, Ichikawa T, Matsuura Y: Length of telomeric repeats in neuroblastoma: Correlation with prognosis and other biological characteristics. Jpn J Cancer Res 83:159-164, 1992.
18. Hiyama E, Yokoyama T, Hiyama K, Yamakido M, Santo T, Kodama T, Ichikawa T, Matsuura Y: Alteration of telomeric repeat length in adult and childhood solid neoplasias. Int J Oncol 6:13-16, 1995.
19. Hiyama K, Ishioka S, Shirotani Y, Inai K, Hiyama E, Murakami I, Isobe T, Inamizu T, Yamakido M: Alterations in telomeric repeat length in lung cancer are associated with loss of heterozygosity in p53 and Rb. Oncogene 10:937-944, 1995.
20. Yamada O, Oshimi K, Motoji T, Mizoguchi H: Telomeric DNA in normal and leukemic blood cells. J Clin Invest 95:1117-1123, 1995.
21. Yamada O, Oshimi K, Mizoguchi H: Telomere reduction in hematologic cells. Int J Hematol 57:181-186, 1993.
22. Adamson DJA, King DJ, Haites NE: Significant telomere shortening in childhood leukemia. Cancer Genet Cytogenet 83:204-206, 1992.
23. Counter CM, Hirte HW, Bacchetti S, Harley CB: Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 91:2900-2904, 1994.
24. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL, Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015, 1994.
25. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S: Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 85:2315-2320, 1995.
26. Ohyashiki JH, Ohyashiki K, Fujimura T, Kawakubo K, Shimamoto T, Iwabuchi A, Toyama K: Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes. Cancer Res 54: 3557-3560, 1994.
27. Foucar K, Langdon RM, Armitage JO, Olson DB, Carroll TJ Jr: Myelodysplastic syndromes: A clinical and pathologic analysis of 109 cases. Cancer 56:553-561, 1985.
28. Mufti GJ, Gallon DA: Myelodysplastic syndromes: Natural history and features of prognostic importance. Clin Haematol 15:953-971, 1986.
29. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C: Proposals for the classification of the myelodysplaslic syndromes. Br J Haematol 51:189-199, 1982.
30. Heim S, Milelman F: Chromosome abnormalities in the myelodysplastic syndromes. Clin Haematol 15:1003-1021, 1986.
31. Mufti GJ: Chromosomal deletions in the myelodysplastic syndrome. Leuk Res 16:35-41, 1992.
32. Tricot G, Boogaerts MA, De Wolf-Peeters C, Van den Berghe H, Verwilghen RL: The myelodysplastic syndromes: Different evolution patterns base on sequential morphological and cylogenetic investigations. Br J Haematol 59:659-670, 1985.
33. Billstrom R, Thiede T, Hansen S, Heim S, Kristoffersson U, Mandahl N, Mittelman F: Bone marrow karyotype and prognosis in primary myelodysplastic syndromes. Eur J Haematol 41:341-346, 1988.
34. Horlike S, Tanlwaki M, Minawa S, Abe T: Chromosome abnormalities and karyotypic evolution in 83 patients with myelodysplastic syndrome and predictive value for prognosis. Cancer 62:1129-1138, 1988.
35. Ohyashiki K, Iwabuchi A, Sasao I, Ohyashiki JH, Ito H, Toyama K: Clinical and cytogenetic significance of myelodysplastic syndromes with disease evolution. Cancer Genet Cytogenet 67:71-78, 1993.
36. Harrison CJ: Diagnosis of malignancy from chromosome preparations. In Rooney DE, Czepulkowski BH (eds): "Human Cytogenetics." Oxford, England: IRL Press, 1986, pp 135-162.
37. Boyum A: Isolation of mononuclear cells and granulocytes from human blood: Isolation of mononuclear cells by one centrifugation and of granulocytes by combining centrifugation and sedimentation at 1g. Scand J Clin Lab Invest 97:(Suppl)77-89, 1986.
38. Kaplan ME, Clark CJ: An improved rosetting assay for detection of human T-lymphocytes. J Immunol Methods 5:131-134, 1974.
39. Sambrook J, Fritsch EF, Maniatis T: "Molecular Cloning: A Laboratory Manual." Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
40. Ohyashiki K, Ohyashiki JH, Fujimura T, Kawakubo K, Shimamoto T, Saito M, Nakazawa S, Toyama K: Telomere shortening in leukemic cells is related to their genetic alterations but not replicative capability. Cancer Genet Cytogenet 78:64-67, 1994.